Increased mean platelet volume in primary Raynaud's phenomenon

References

• Herrick AL. Pathogenesis of Raynaud's phenomenon. Rheumatology (Oxford) 2005; 44: 587–596
   PubMed Web of Science ®Google Scholar
• Bath PM, Butterworth RJ. Platelet size: Measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996; 7: 157–161
   PubMed Web of Science ®Google Scholar
• Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: A link between thrombosis and inflammation?. Curr Pharm Des 2011; 17: 47–58
   PubMed Web of Science ®Google Scholar
• Kappelmayer J, Nagy B, Jr, Miszti-Blasius K, Hevessy Z, Setiadi H. The emerging value of P-selectin as a disease marker. Clin Chem Lab Med 2004; 42: 475–486
   PubMed Web of Science ®Google Scholar
• Mannaioni PF, Di Bello MG, Masini E. Platelets and inflammation: Role of platelet-derived growth factor, adhesion molecules and histamine. Inflamm Res 1997; 46: 4–18
   PubMed Web of Science ®Google Scholar
• Huczek Z, Kochman J, Filipiak KJ, Horszczaruk GJ, Grabowski M, Piatkowski R, Wilczynska J, Zielinski A, Meier B, Opolski G. Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol 2005; 46: 284–290
   PubMed Web of Science ®Google Scholar
• Tschoepe D, Roesen P, Esser J, Schwippert B, Nieuwenhuis HK, Kehrel B, Gries FA. Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost 1991; 17: 433–438
   PubMed Web of Science ®Google Scholar
• Davi G, Romano M, Mezzetti A, Procopio A, Iacobelli S, Antidormi T, Bucciarelli T, Alessandrini P, Cuccurullo F, Bittolo Bon G. Increased levels of soluble P-selectin in hypercholesterolemic patients. Circulation 1998; 97: 953–957
   PubMed Web of Science ®Google Scholar
• Garbaraviciene J, Diehl S, Varwig D, Bylaite M, Ackermann H, Ludwig RJ, Boehncke WH. Platelet P-selectin reflects a state of cutaneous inflammation: Possible application to monitor treatment efficacy in psoriasis. Exp Dermatol 2010; 19: 736–741
   PubMed Web of Science ®Google Scholar
• Gasparyan AY, Stavropoulos-Kalinoglou A, Toms TE, Douglas KM, Kitas GD. Association of mean platelet volume with hypertension in rheumatoid arthritis. Inflamm Allergy Drug Targets 2010; 9: 45–50
   PubMedGoogle Scholar
• Wigley FM. Clinical practice. Raynaud's Phenomenon. N Engl J Med 2002; 347: 1001–1008
   PubMed Web of Science ®Google Scholar
• Nagy B, Jr, Csongradi E, Bhattoa HP, Balogh I, Blasko G, Paragh G, Kappelmayer J, Kaplar M. Investigation of Thr715Pro P-selectin gene polymorphism and soluble P-selectin levels in type 2 diabetes mellitus. Thromb Haemost 2007; 98: 186–191
   PubMed Web of Science ®Google Scholar
• Berger JS, Eraso LH, Xie D, Sha D, Mohler ER, 3rd. Mean platelet volume and prevalence of peripheral artery disease, the National Health and Nutrition Examination Survey, 1999–2004. Atherosclerosis 2010; 213: 586–591
   PubMed Web of Science ®Google Scholar
• Polidoro L, Barnabei R, Giorgini P, Petrazzi L, Ferri C, Properzi G, Platelet activation in patients with the Raynaud's Phenomenon. Intern Med J 2010; accepted
   Google Scholar
• Oyabu C, Morinobu A, Sugiyama D, Saegusa J, Tanaka S, Morinobu S, Tsuji G, Kasagi S, Kawano S, Kumagai S. Plasma Platelet-derived microparticles in patients with connective tissue diseases. J Rheumatol 2011; 38: 680–684
   PubMed Web of Science ®Google Scholar
• Pamuk GE, Turgut B, Pamuk ON, Vural O, Demir M, Cakir N. Increased circulating platelet-leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis: A comparative study. Blood Coagul Fibrinolysis 2007; 18: 297–302
   PubMed Web of Science ®Google Scholar
• Nigrovic PA, Fuhlbrigge RC, Sundel RP. Raynaud's phenomenon in children: A retrospective review of 123 patients. Pediatrics 2003; 111: 715–721
   PubMed Web of Science ®Google Scholar
• Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, Douglas KM, Kitas GD. Platelet function in rheumatoid arthritis: Arthritic and cardiovascular implications. Rheumatol Int 2011; 31: 153–164
   PubMed Web of Science ®Google Scholar
• Bath P, Algert C, Chapman N, Neal B. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 2004; 35: 622–626
   PubMed Web of Science ®Google Scholar
• Gasparyan AY, Sandoo A, Stavropoulos-Kalinoglou A, Kitas GD. Mean platelet volume in patients with rheumatoid arthritis: The effect of anti-TNF-alpha therapy. Rheumatol Int 2010; 30: 1125–1129
   PubMed Web of Science ®Google Scholar
• Yazici S, Yazici M, Erer B, Calik Y, Ozhan H, Ataoglu S. The platelet indices in patients with rheumatoid arthritis: Mean platelet volume reflects disease activity. Platelets 2010; 21: 122–125
   PubMed Web of Science ®Google Scholar
• Milovanovic M, Nilsson E, Jaremo P. Relationships between platelets and inflammatory markers in rheumatoid arthritis. Clin Chim Acta 2004; 343: 237–240
   PubMed Web of Science ®Google Scholar
• Kisacik B, Tufan A, Kalyoncu U, Karadag O, Akdogan A, Ozturk MA, Kiraz S, Ertenli I, Calguneri M. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine 2008; 75: 291–294
   PubMed Web of Science ®Google Scholar